Evidence that mutations in JAK2, CALR, or MPL are sufficient to engender an MPN phenotype has been provided by mouse models, where expression of each mutation alone accurately re-capitulate distinctive features of human disease [2,3,4,5]. This evidence concerns the gene MPL and myeloproliferative disorder.